Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 21, 2020
Advances with Long Non-Coding RNAs in Diabetic Peripheral NeuropathyMen Wu, Yonghao Feng, Xiaohong ShiInternational Journal of Molecular Sciences|March 14, 2026
The Role of Non-Coding RNAs in the Pathogenesis and Progression of Diabetic Kidney DiseaseYinfeng Guo, Yonghao Feng, Henglan Wu, et al.Life Sciences|June 12, 2025
Roles of focal adhesion proteins in obesity related metabolic syndromeYonghao Feng, Hanyin Zhang, Wei Wu, et al.Frontiers in Pharmacology|July 26, 2018
The Protective Effect of Astaxanthin on Cognitive Function via Inhibition of Oxidative Stress and Inflammation in the Brains of Chronic T2DM RatsYonghao Feng, Aiqun Chu, Qiong Luo, et al.Drug Design, Development and Therapy|February 6, 2018
Involvement of microRNA-146a in diabetic peripheral neuropathy through the regulation of inflammationYonghao Feng, Long Chen, Qiong Luo, et al.Biological & Pharmaceutical Bulletin|May 8, 2019
MicroRNA-146a-5p Downregulates the Expression of P-Glycoprotein in Rats with Lithium-Pilocarpine-Induced Status EpilepticusXiaolin Deng, Yiye Shao, Yangmei Xie, et al.Neurochemical Research|October 19, 2016
Protective Effects of Thymoquinone Against Convulsant Activity Induced by Lithium-Pilocarpine in a model of Status EpilepticusYiye Shao, Yonghao Feng, Yangmei Xie, et al.Endocrine Journal|January 17, 2024
Protective effect of alirocumab, a PCSK9 inhibitor, on the sciatic nerve of rats with diabetic peripheral neuropathyNa Cui, Yonghao Feng, Ming Wang, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|February 29, 2020
Long Non‑Coding RNAs Regulate Inflammation in Diabetic Peripheral Neuropathy by Acting as ceRNAs Targeting miR-146a-5pYonghao Feng, Ying Ge, Men Wu, et al.CNS & Neurological Disorders Drug Targets|May 6, 2017
Involvement of microRNA-146a in the Inflammatory Response of S tatus Epilepticus RatsQiong Luo, Zhen Ren, Linlin Zhu, et al.Pageof 3